SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 303 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $25,629,000 | -35.9% | 148,310 | -57.4% | 0.48% | -35.8% |
| Q4 2014 | $39,981,000 | -26.2% | 347,845 | +0.4% | 0.74% | -28.0% |
| Q3 2014 | $54,145,000 | -9.7% | 346,550 | -28.7% | 1.03% | -0.1% |
| Q2 2014 | $59,989,000 | +20.9% | 486,335 | +1.5% | 1.03% | +23.2% |
| Q1 2014 | $49,633,000 | +15.1% | 479,040 | -0.0% | 0.84% | +16.2% |
| Q4 2013 | $43,104,000 | +36.1% | 479,250 | +1.2% | 0.72% | +28.6% |
| Q3 2013 | $31,682,000 | +0.8% | 473,720 | -0.3% | 0.56% | -9.4% |
| Q2 2013 | $31,438,000 | – | 475,250 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |